Milestone Pharmaceuticals

Milestone Pharmaceuticals is a development company that creates novel small-molecule therapeutic drugs based on clinically validated cardiovascular disease mechanisms. The company's lead product is a novel and effective short-acting calcium channel antagonist used for systemic treatment of transient cardiovascular conditions such as atrial arrhythmias and angina.